BNP Paribas Put 420 GS 21.06.2024/ DE000PC2YCR4 /
05/06/2024 21:50:20 | Chg.-0.025 | Bid21:57:57 | Ask21:57:57 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.034EUR | -42.37% | 0.033 Bid Size: 10,000 |
0.091 Ask Size: 10,000 |
Goldman Sachs Group ... | 420.00 USD | 21/06/2024 | Put |
GlobeNewswire
01:53
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GlobeNewswire
05/06
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
05/06
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
05/06
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
05/06
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...
GlobeNewswire
05/06
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
09/05
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
11/04
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties